Logo image of XX.CA

AVANTE CORP (XX.CA) Stock Fundamental Analysis

TSX-V:XX - TSX Venture Exchange - CA05352F1099 - Common Stock - Currency: CAD

0.99  -0.01 (-1%)

Fundamental Rating

2

Taking everything into account, XX scores 2 out of 10 in our fundamental rating. XX was compared to 3 industry peers in the Diversified Consumer Services industry. The financial health of XX is average, but there are quite some concerns on its profitability. XX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year XX has reported negative net income.
In the past year XX has reported a negative cash flow from operations.
In the past 5 years XX reported 4 times negative net income.
In multiple years XX reported negative operating cash flow during the last 5 years.
XX.CA Yearly Net Income VS EBIT VS OCF VS FCFXX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.53%, XX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
XX has a Return On Equity of -30.89%. This is in the better half of the industry: XX outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -16.53%
ROE -30.89%
ROIC N/A
ROA(3y)-7.38%
ROA(5y)-6.82%
ROE(3y)-16.52%
ROE(5y)-18.55%
ROIC(3y)N/A
ROIC(5y)N/A
XX.CA Yearly ROA, ROE, ROICXX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Gross Margin of XX (41.85%) is better than 66.67% of its industry peers.
XX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for XX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.09%
GM growth 5Y6.74%
XX.CA Yearly Profit, Operating, Gross MarginsXX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

XX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XX has been increased compared to 1 year ago.
XX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for XX has been reduced compared to a year ago.
XX.CA Yearly Shares OutstandingXX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
XX.CA Yearly Total Debt VS Total AssetsXX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.51, we must say that XX is in the distress zone and has some risk of bankruptcy.
XX's Altman-Z score of 1.51 is amongst the best of the industry. XX outperforms 100.00% of its industry peers.
XX has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
XX has a better Debt to Equity ratio (0.06) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACCN/A
WACC9.02%
XX.CA Yearly LT Debt VS Equity VS FCFXX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.69 indicates that XX should not have too much problems paying its short term obligations.
XX has a better Current ratio (1.69) than 100.00% of its industry peers.
A Quick Ratio of 1.53 indicates that XX should not have too much problems paying its short term obligations.
XX has a Quick ratio of 1.53. This is amongst the best in the industry. XX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.53
XX.CA Yearly Current Assets VS Current LiabilitesXX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

XX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.50%.
The Revenue has grown by 42.42% in the past year. This is a very strong growth!
Measured over the past years, XX shows a decrease in Revenue. The Revenue has been decreasing by -4.90% on average per year.
EPS 1Y (TTM)-5.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.33%
Revenue 1Y (TTM)42.42%
Revenue growth 3Y-35.21%
Revenue growth 5Y-4.9%
Sales Q2Q%51.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XX.CA Yearly Revenue VS EstimatesXX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
XX.CA Yearly EPS VS EstimatesXX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XX.CA Price Earnings VS Forward Price EarningsXX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XX.CA Per share dataXX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTE CORP

TSX-V:XX (3/7/2025, 7:00:00 PM)

0.99

-0.01 (-1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-25 2025-02-25
Earnings (Next)07-28 2025-07-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners24.05%
Ins Owner ChangeN/A
Market Cap26.38M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB 4.48
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.13
BVpS0.47
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.53%
ROE -30.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.85%
FCFM N/A
ROA(3y)-7.38%
ROA(5y)-6.82%
ROE(3y)-16.52%
ROE(5y)-18.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.09%
GM growth 5Y6.74%
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.26%
Cap/Sales 1.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.53
Altman-Z 1.51
F-Score4
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)39.51%
Cap/Depr(5y)29.78%
Cap/Sales(3y)2.23%
Cap/Sales(5y)1.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.42%
Revenue growth 3Y-35.21%
Revenue growth 5Y-4.9%
Sales Q2Q%51.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-95.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.78%
OCF growth 3YN/A
OCF growth 5YN/A